| |
|
|
|
| Unsafe Drugs
:: Seroquel
|
SEROQUEL - In 1997, Seroquel was approved by the FDA to treat individuals suffering from schizophrenia and bipolar disorder. However, it was often prescribed to treat "off-label" disorders as well like autism and dementia thanks in large part to the manufacturer, AstraZeneca (NYSE: AZN), promoting these unapproved, "off-label" uses.
Beginning in 2003, the FDA began to take notice of reports of hyperglycemia and diabetes occuring at an alarming rate in patients that had been prescribed Seroquel. Subsequently, in 2004, the FDA required AstraZeneca to add a label warning of these serious side effects.
In 2005, Seroquel was finally required to carry a black box warning, the FDA's highest such safety warning, after a clinical study found that when Seroquel was prescribed for dementia, which is not an approved use of the drug, the mortality rate is considerably higher in patients that are given Seroquel than those patients given a placebo.
The reason why this is a concern is that AstraZeneca was using false and misleading promotional material leading to the drug being used for conditions for which it was not intended nor approved by the FDA. In fact, the FDA issued a warning letter to AstraZeneca asserting that the company not only used misleading marketing material, but also failed to make doctors and patients aware of the side effects.
As mentioned above, diabetes and hyperglycemia are the two leading side effects associated with this drug whether it was prescribed for approved uses or not. But there is also the risk of heart failure or sudden death, especially when taken for "off-label" uses. We believe that AstraZeneca only exacerbated the problem by marketing this defective and unsafe drug for conditions it was never supposed to treat.
Their defective drug not only harmed the people for whom it was intended, but also thousands of others due to their deceptive and outlandish marketing. We intend to hold them accountable for their negligent actions.
Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of using Seroquel, please fill out the form below for a free evaluation.
Keywords: Seroquel Lawsuit | Seroquel Lawyers | Seroquel Attorneys | Seroquel Lawyer | Seroquel Attorney
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Seroquel In the News |
FDA panel backs use of AstraZeneca's Brilinta - The News Journal
TopNews Arab EmiratesFDA panel backs use of AstraZeneca's BrilintaThe News JournalThe heartburn medicine Nexium and the antipsychotic Seroquel, the company's two best sellers, accounted for nearly $10 billion of the...
More Information »
A Glass Half Full: Avandia Case Reveals Hole in FDA's Conflict-of-Interest Rules - BNET
BNETA Glass Half Full: Avandia Case Reveals Hole in FDA's Conflict-of-Interest RulesBNETThe news that one of the doctors on an FDA panel assessing whether GlaxoSmithKline (GSK)'s diabetes drug Avandia causes too...
More Information »
AstraZeneca Likely to Double 2010 Share Buyback After Crestor Legal Win - Bloomberg
AstraZeneca Likely to Double 2010 Share Buyback After Crestor Legal WinBloombergAn FDA panel will on July 28 consider Brilinta for approval and recommend whether the product should be cleared as a competitor to Plavix, ...and...
More Information »
(AZN) SqueezeTrigger Price is $47.813. There is $543819684.00 That Short ... - TMCnet
(AZN) SqueezeTrigger Price is $47.813. There is $543819684.00 That Short ...TMCnetThe Company's products include Arimidex, Crestor, Nexium, Seroquel and Symbicort. AstraZeneca's operations are focused on prescription...
More Information »
Expertos EEUU recomiendan anticoagulante AstraZeneca - Buena Salud
Expertos EEUU recomiendan anticoagulante AstraZenecaBuena SaludLos miembros del panel asesor de la Administración de Alimentos y Medicamentos de Estados Unidos (FDA por su sigla en inglés) votaron 7-1 por recomendar la ...and...
More Information »
Anticoagulante de AstraZeneca recibe críticas mixtas en FDA - Terra.com
Anticoagulante de AstraZeneca recibe críticas mixtas en FDATerra.comPero en documentos divulgados el lunes, el regulador de la FDA Thomas Marciniak dijo que "las dosis de aspirina no explican los resultados...
More Information »
|
|
| |